DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie


Slamon D, Neven P, Chia S. et al.
Overall survival results of the Phase III MONALEESA‑3 trial of postmenopausal patients with hormone receptor-positive human-epidermal growth factor-2-negative advanced breast cancer treated with fulvestrant plus/minus ribociclib.

Ann Oncol 2019;
30 (Suppl. 05) v851-v934

Download Bibliographical Data

Search in: